| A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years (NCT04899336) | Janssen Research & Development, LLC | 2021-06-30 |
| A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants (NCT04911543) | Janssen Research & Development, LLC | 2021-06-23 |
| A Study of Guselkumab in Adult Participants With Celiac Disease (NCT04704843) | Janssen Research & Development, LLC | 2021-06-17 |
| A Study of Guselkumab in Participants With Active Psoriatic Arthritis (NCT04882098) | Janssen Research & Development, LLC | 2021-06-17 |
| A Study of JNJ-69095897 in Healthy Participants (NCT04920578) | Janssen Research & Development, LLC | 2021-06-16 |
| Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440 (NCT03890341) | Janssen Research & Development, LLC | 2021-06-01 |
| A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants (NCT04712006) | Janssen Research & Development, LLC | 2021-05-30 |
| A Study of JNJ-68179280 in Healthy Participants (NCT04844463) | Janssen Research & Development, LLC | 2021-05-26 |
| A Study of Nipocalimab in Healthy Male and Female Participants (NCT04848558) | Janssen Research & Development, LLC | 2021-05-25 |
| A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy (NCT04836559) | Janssen Research & Development, LLC | 2021-05-18 |
| A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT) (NCT04264806) | Janssen Research & Development, LLC | 2021-05-06 |
| A Study of JNJ-56136379 in Healthy Participants (NCT04853524) | Janssen Research & Development, LLC | 2021-05-06 |
| A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (NCT04791319) | Janssen Research & Development, LLC | 2021-05-03 |
| ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer (NCT04662580) | Janssen Research & Development, LLC | 2021-05-03 |
| A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil (NCT04540744) | Janssen Research & Development, LLC | 2021-04-30 |
| A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 (NCT04844450) | Janssen Research & Development, LLC | 2021-04-29 |
| A Study of JNJ-67835989 in Healthy Participants (NCT04844411) | Janssen Research & Development, LLC | 2021-04-27 |
| A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants (NCT04844424) | Janssen Research & Development, LLC | 2021-04-14 |
| A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants (NCT04816513) | Janssen Research & Development, LLC | 2021-04-14 |
| A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease (NCT04673357) | Janssen Research & Development, LLC | 2021-04-06 |
| A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants (NCT04616677) | Janssen Research & Development, LLC | 2021-03-31 |
| A Study of JNJ-64304500 in Participants With Alopecia Areata (NCT04740970) | Janssen Research & Development, LLC | 2021-03-24 |
| A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) (NCT04630028) | Janssen Research & Development, LLC | 2021-03-17 |
| A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma (NCT04722146) | Janssen Research & Development, LLC | 2021-03-12 |
| A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (NCT04585789) | Janssen Research & Development, LLC | 2021-03-11 |
| A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix (NCT04821323) | Janssen Research & Development, LLC | 2021-03-10 |
| A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants (NCT04569695) | Janssen Research & Development, LLC | 2021-03-08 |
| A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease (NCT04655807) | Janssen Research & Development, LLC | 2021-03-03 |
| A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NCT04657224) | Janssen Research & Development, LLC | 2021-02-25 |
| A Study of JNJ-64300535 in Healthy Participants (NCT04736147) | Janssen Research & Development, LLC | 2021-02-03 |
| A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04634552) | Janssen Research & Development, LLC | 2021-02-01 |
| A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection (NCT04667104) | Janssen Research & Development, LLC | 2021-02-01 |
| A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions (NCT04718805) | Janssen Research & Development, LLC | 2021-01-26 |
| A Study to Compare Two Different Subcutaneously-administered JNJ-64304500 Formulations in Healthy Participants (NCT04667052) | Janssen Research & Development, LLC | 2021-01-13 |
| A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease (NCT04619420) | Janssen Research & Development, LLC | 2021-01-06 |
| A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents (NCT04661397) | Janssen Research & Development, LLC | 2021-01-05 |
| A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy (NCT04640623) | Janssen Research & Development, LLC | 2020-12-18 |
| A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04586426) | Janssen Research & Development, LLC | 2020-12-15 |
| A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis (NCT04633447) | Janssen Research & Development, LLC | 2020-12-10 |
| A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (NCT04658862) | Janssen Research & Development, LLC | 2020-12-07 |
| Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04671433) | Janssen Research & Development, LLC | 2020-12-04 |
| Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04794101) | Janssen Research & Development, LLC | 2020-12-04 |
| A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy Participants (NCT04617691) | Janssen Research & Development, LLC | 2020-11-30 |
| A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT04609826) | Janssen Research & Development, LLC | 2020-11-26 |
| A Study of JNJ-73763989 in Healthy Chinese Adult Participants (NCT04586439) | Janssen Research & Development, LLC | 2020-11-24 |
| A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) (NCT04540796) | Janssen Research & Development, LLC | 2020-11-20 |
| A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer (NCT04577833) | Janssen Research & Development, LLC | 2020-11-13 |
| A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer (NCT04644770) | Janssen Research & Development, LLC | 2020-11-12 |
| A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies (NCT04606381) | Janssen Research & Development, LLC | 2020-11-10 |
| A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression (NCT04599855) | Janssen Research & Development, LLC | 2020-11-04 |
| A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2 (NCT04611971) | Janssen Research & Development, LLC | 2020-10-27 |
| A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1 (NCT04589026) | Janssen Research & Development, LLC | 2020-10-21 |
| A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses (NCT04544826) | Janssen Research & Development, LLC | 2020-10-16 |
| A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions (NCT04538664) | Janssen Research & Development, LLC | 2020-10-13 |
| A Study of JNJ-77474462 in Healthy Participants (NCT04544813) | Janssen Research & Development, LLC | 2020-10-13 |
| A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT04487080) | Janssen Research & Development, LLC | 2020-09-30 |
| A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy (NCT04571697) | Janssen Research & Development, LLC | 2020-09-28 |
| A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (NCT04497844) | Janssen Research & Development, LLC | 2020-09-23 |
| A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (NCT04535544) | Janssen Research & Development, LLC | 2020-09-17 |
| A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04557098) | Janssen Research & Development, LLC | 2020-09-17 |
| A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant (NCT04533529) | Janssen Research & Development, LLC | 2020-09-16 |
| A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy (NCT04532749) | Janssen Research & Development, LLC | 2020-09-15 |
| A Study of Guselkumab in Participants With Active Lupus Nephritis (NCT04376827) | Janssen Research & Development, LLC | 2020-09-15 |
| A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection (NCT04439539) | Janssen Research & Development, LLC | 2020-09-14 |
| A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants (NCT04410094) | Janssen Research & Development, LLC | 2020-09-14 |
| A Study of JNJ-64251330 in Healthy Participants (NCT04552197) | Janssen Research & Development, LLC | 2020-09-02 |
| A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants (NCT04474210) | Janssen Research & Development, LLC | 2020-08-19 |
| A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases (NCT04523207) | Janssen Research & Development, LLC | 2020-08-19 |
| A Study of JNJ-53718678 in Participants With Hepatic Impairment (NCT04332523) | Janssen Research & Development, LLC | 2020-08-17 |
| A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (NCT04508023) | Janssen Research & Development, LLC | 2020-08-13 |
| Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD (NCT04494360) | Janssen Research & Development, LLC | 2020-08-07 |
| A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants (NCT04480736) | Janssen Research & Development, LLC | 2020-07-28 |
| A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants (NCT04543383) | Janssen Research & Development, LLC | 2020-07-27 |
| A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants (NCT04453189) | Janssen Research & Development, LLC | 2020-07-20 |
| A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder (NCT04451187) | Janssen Research & Development, LLC | 2020-07-16 |
| A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus (NCT04060888) | Janssen Research & Development, LLC | 2020-07-14 |
| A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male Participants (NCT04410081) | Janssen Research & Development, LLC | 2020-07-14 |
| A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors (NCT04397276) | Janssen Research & Development, LLC | 2020-07-10 |
| A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NCT04210219) | Janssen Research & Development, LLC | 2020-07-02 |
| A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (NCT04457960) | Janssen Research & Development, LLC | 2020-07-01 |
| A Study of JNJ-70033093 in Healthy Participants (NCT04448964) | Janssen Research & Development, LLC | 2020-06-26 |
| A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants (NCT04300621) | Janssen Research & Development, LLC | 2020-06-19 |
| A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma (NCT04181827) | Janssen Research & Development, LLC | 2020-06-12 |
| A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure (NCT04252287) | Janssen Research & Development, LLC | 2020-03-10 |
| A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) (NCT04172675) | Janssen Research & Development, LLC | 2020-02-28 |
| A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants (NCT04282746) | Janssen Research & Development, LLC | 2020-02-18 |
| A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants (NCT04258189) | Janssen Research & Development, LLC | 2020-02-11 |
| A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants (NCT04235270) | Janssen Research & Development, LLC | 2020-01-17 |
| A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants (NCT04225078) | Janssen Research & Development, LLC | 2020-01-17 |
| A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants (NCT04223349) | Janssen Research & Development, LLC | 2020-01-10 |
| A Study of JNJ-70033093 and Digoxin in Healthy Participants (NCT04206488) | Janssen Research & Development, LLC | 2020-01-09 |
| A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma (NCT04121260) | Janssen Research & Development, LLC | 2019-12-25 |
| A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants (NCT04208373) | Janssen Research & Development, LLC | 2019-12-20 |
| A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM) (NCT04042376) | Janssen Research & Development, LLC | 2019-12-18 |
| A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants (NCT04208061) | Janssen Research & Development, LLC | 2019-12-18 |
| A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) (NCT04108208) | Janssen Research & Development, LLC | 2019-12-17 |
| A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants (NCT04185051) | Janssen Research & Development, LLC | 2019-12-17 |
| A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) (NCT04193046) | Janssen Research & Development, LLC | 2019-12-16 |
| Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese Participants (NCT04030533) | Janssen Research & Development, LLC | 2019-11-29 |
| A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations (NCT04083976) | Janssen Research & Development, LLC | 2019-11-20 |